Profit setback for Simcere Pharma in novel drugs quest
The pharmaceutical company’s profits have been buffeted by erratic returns on an equity stake in a fellow developer of innovative drugs Key Takeaways: Simcere Pharmaceutical holds a 9% stake in…
Fast-growing Duoning Biotech seeks winning formula for pricey IPO
The provider of bioprocessing services for the drugs sector has been expanding rapidly via aggressive M&A, backed by big-name investors Key Takeaways: WuXi Biologics is Duoning Biotechnology’s biggest client and…
CSPC Pharma wins China’s mRNA vaccine race, but just not fast enough
Drugmaker CSPC Pharma gets the green light to produce China’s first homegrown mRNA vaccine, but the breakthrough comes too late in the pandemic to impress investors Key Takeaways: News of…
Sihuan Pharma’s Botox Beauty Bid Suffers Covid Wrinkle
The cardiovascular and cancer drug maker’s recent shift to the medical beauty business was doing well at first, but struggled last yearKey Takeaways:Sihuan Pharmaceutical’s recent move into the medical beauty…
After Ditching Promising Drug, Everest Medicines Bets on mRNA
The drug maker surprised investors last year when it halted its tie-up with Gilead to develop the breast cancer drug Trodelvy. Now it says it will focus on mRNA vaccinesKey…
Recent Articles
RELATED ARTICLES
-
FAST NEWS: Simcere’s revenue jumps on rising innovative drug sales
2096.HK -
CStone breaks up with drugs partner as U.S. rollout stalls
2616.HK
-
AstraZeneca pays hefty price for Chinese weight-loss drug
AZN.US
-
FAST NEWS: Simcere gets exclusive rights to innovative influenza drug
2096.HK
-
BeiGene goes for global growth with sales and R&D push
BGNE.US 6160.HK
-
Everest reaches new heights on growing drug sales
1952.HK
- InSilico seeks IPO boost to get AI drugs over the line
